Article
Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens.
Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada.
Molecular & Cellular Proteomics (impact factor:
7.4).
06/2012;
11(9):692-709.
DOI:10.1074/mcp.M111.013672
Source: PubMed
-
Citations (0)
-
Cited In (0)
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
amino acids
C. rodentium
cell culture-based mass spectrometry
Citrobacter rodentium
conventional molecular
effacing bacterial pathogens
effacing pathogens
enterohemorrhagic E. coli
enteropathogenic Escherichia coli
EPEC type III-secreted proteins
Gram-negative bacterial pathogens
human pathogen
potential therapeutics
predicted molecular mass
Salmonella enterica serovar Typhimurium
sensitive proteomics tool
Type III secretion systems
type III secretome
type III secretomes
type III-secreted effectors